2 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Angitia Incorporated Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS) AGA2118 - Healthy Participants, Pharmacokinetic Study | Phase 1 | Completed | Angitia Incorporated Limited | 28 | 2026-01-05 | 2026-09-10 |
| Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) AGA2115, Placebo - Osteogenesis Imperfecta (OI) | Phase 2 | Recruiting | Angitia Incorporated Limited | 80 | 2025-12-12 | 2026-10-14 |
| A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers AGA2115, Placebo - Osteogenesis Imperfecta | Phase 1 | Completed | Angitia Incorporated Limited | 72 | 2023-10-03 | 2025-01-10 |
United States (3) · Argentina (1) · Australia (1) · Canada (1) · Denmark (1) · France (1) · Netherlands (1) · United Kingdom (1)